Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated With Thrombopoietin Receptor Agonists. Mediterr J Hematol Infect Dis 2023, 15 (1), e2023021. https://doi.org/10.4084/MJHID.2023.021.